Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)’s Basic Consolidated EPS Came In At $0.4896

0

The annual basic consolidated EPS for Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) posted annual basic consolidated EPS of $0.4896 for the year period ended2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $0.4896.

What About EPS from continuing operations

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)’s EPS from continuing operations for the annual period ended 2015-12-31 came in at 0.4896. On quarterly basis, EPS from continuing operations stood at $0.4896 for the three-month period ended 2015-12-31.

EPS contribution from parent

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) received of $0.4896 EPS boost from the parent company for the annual period ended 2015-12-31. For the quarter period ended 2015-12-31, the company received EPS boost of $0.4896 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2015-12-31 was$0.49, but for the quarter period ended 2015-12-31 the basic net EPS was $0.49.

What About Consolidated Diluted EPS?

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) posted consolidated diluted EPS of $0.4893 for the annual period ended 2015-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2015-12-31 stood at $0.4893.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $0.4893 for the annual period ended 2015-12-31. On quarter basis, diluted EPS from continuing operations was $0.4893 for the three-month period ended 2015-12-31.

Net diluted EPS

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) posted net diluted EPS of $0.49for the annual period ended 2015-12-31. On the other hand, it posted net diluted EPS of $0.49 for thequarterly period ended 2015-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) contributed diluted EPS of $0.4893. The diluted EPS contribution from the parent for the quarter ended 2015-12-31 stood at $0.4893.

The company’s net basic EPS for the annual period ended 2015-12-31 was $0.49 while for the quarter period ended 2015-12-31 it was $0.49.

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) had average basic shares outstanding of 44.197 for the annual period ended 2015-12-31 and 44.197 for the quarter period ended 2015-12-31.The number of diluted shares outstanding was 44.22 for the annual period ended 2015-12-31 and 44.22 for the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 44 times, 1 visits today)